In CRC, frequent mutations in HNF1A were reported in microsatellite instability-high (MSI-H) tumors15, but mutation rates in all colorectal cancer patients, including microsatellite stable (MSS) tumors were only 2%16. This evidence concerns the gene HNF1A and colorectal cancer.